Jan Nolta, PhD

Research Interests:  I direct the Cell & Gene Therapy program at UC Davis. Our team develops and manufactures Chimeric Antigen Receptor (CAR)- T lymphocytes for clinical use. We have a translational laboratory for the research, an immune deficient mouse vivarium to test human gene-modified cellular products for the FDA, and a Good Manufacturing Practice Facility to produce lentiviral vectors, transduce and expand the patient cells for use in clinical trials.